E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers V > Headlines for ViaCell Inc. > News item
Published on 10/25/2007 in the Prospect News Special Situations Daily.

PerkinElmer clears waiting period hurdle in tender for ViaCell

By Lisa Kerner

Charlotte, N.C., Oct. 25 - The Hart-Scott-Rodino waiting period has ended in PerkinElmer, Inc.'s $7.25-per-share cash tender offer for ViaCell, Inc., it was announced on Thursday.

PerkinElmer subsidiary Victor Acquisition Corp. began the tender offer on Oct. 12, with the offer slated to end at midnight ET on Nov. 8.

PerkinElmer is a Waltham, Mass.-based health sciences and photonics company. ViaCell is a biotechnology company based in Cambridge, Mass.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.